Evoke Pharma Inc
NASDAQ:EVOK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evoke Pharma Inc
NASDAQ:EVOK
|
US |
|
H
|
Hyundai Motor Co
XMUN:HYU
|
KR |
|
A
|
Adyen NV
F:1N8
|
NL |
|
Firstcash Holdings Inc
NASDAQ:FCFS
|
US |
|
Ventia Services Group Ltd
ASX:VNT
|
AU |
|
Calcom Vision Ltd
BSE:517236
|
IN |
|
COG Financial Services Ltd
ASX:COG
|
AU |
|
J
|
J B Hunt Transport Services Inc
DUS:JB1
|
US |
|
I
|
Intrum AB
XBER:IJU
|
SE |
|
Weibo Corp
NASDAQ:WB
|
CN |
|
Seagate Technology Holdings PLC
NASDAQ:STX
|
IE |
|
S
|
Sailfish Royalty Corp
XTSX:FISH
|
VG |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
JP |
|
I
|
Indofood CBP Sukses Makmur Tbk PT
XBER:48I
|
ID |
|
Portillos Inc
NASDAQ:PTLO
|
US |
|
Beacon Lighting Group Ltd
ASX:BLX
|
AU |
|
N
|
Northrop Grumman Corp
XMUN:NTH
|
US |
|
A
|
Andean Precious Metals Corp
XTSX:APM
|
CA |
|
Ardelyx Inc
NASDAQ:ARDX
|
US |
|
G
|
Gatos Silver Inc
TSX:GATO
|
US |
|
V
|
VSTECS Holdings Ltd
HKEX:856
|
HK |
|
Cherry SE
F:C3RY
|
DE |
|
D
|
Dongfang Electric Corp Ltd
OTC:DNGFF
|
CN |
|
Sovereign Metals Ltd
ASX:SVM
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVOK's stock price target?
Not Available
EVOK does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Evoke Pharma Inc?
Projected CAGR
52%
The compound annual growth rate for Revenue over the next 3 years is 52%.